CRISPR-Cas9 Therapy
Genetic Disorders, Cancer
Pre-clinical/Early ClinicalActive
Key Facts
About Essen Biotech
Essen Biotech is a private, clinical-stage biotech firm pioneering personalized cellular and gene therapies for oncology and genetic disorders. Leveraging a broad platform encompassing CAR-T, TILs, NK cells, CRISPR, and MSC therapies, the company aims to address unmet medical needs through cutting-edge research. While its website suggests a global patient-facing service model, the core appears to be therapeutic development, likely positioning it as a pre-revenue entity advancing programs through clinical trials. Key challenges include navigating complex clinical pathways, securing sustained funding, and differentiating in the competitive cell therapy landscape.
View full company profile